Literature DB >> 35313774

Another Sherlock Holmes Mystery: Abdominal Pain Explained by Median Arcuate Ligament Syndrome.

Andrew J Ortega1, Hadiqa Memon1, Bhavi Trivedi1, Brian Davis1, Richard McCallum1.   

Abstract

Median arcuate ligament syndrome (MALS), also known as celiac artery compression syndrome, is a rare gastrointestinal condition with an estimated incidence of 2 per 100 000 population. Predominantly in female patients, this syndrome is characterized by the compression of the celiac artery at its origin from the aorta by the median arcuate ligament, which at the same time is entrapping the celiac plexus, causing upper abdominal pain, notably postprandial pain, as well as nausea, vomiting, food aversion, and weight loss. We present a case of abdominal pain secondary to MALS that was appropriately diagnosed after requiring narcotic medication, which responded to surgical therapy.

Entities:  

Keywords:  gastroenterology; median arcuate ligament syndrome

Mesh:

Year:  2022        PMID: 35313774      PMCID: PMC8948318          DOI: 10.1177/23247096221084911

Source DB:  PubMed          Journal:  J Investig Med High Impact Case Rep        ISSN: 2324-7096


Introduction

Median arcuate ligament syndrome (MALS), also known as celiac artery compression syndrome, is a rare diagnosis only deduced after excluding more common entities. Compression results from either a low insertion of the diaphragmatic fibers or a high origin of the celiac artery resulting in compression of the celiac ganglion and its associated fibers. However, not all patients with this anatomic compression are symptomatic. The median arcuate ligament is a band of fibrous tissue that passes over the aorta, essentially providing a “tunnel” as the aorta passes through the diaphragm (Figure 1).
Figure 1.

Anatomical association of the median arcuate ligament (MAL) to the diaphragm and aorta. Blue arrow highlights the location of the MAL.

Reproduced from McCallum and Al-Bayati with permission from Practical Gastro.[2,3]

Anatomical association of the median arcuate ligament (MAL) to the diaphragm and aorta. Blue arrow highlights the location of the MAL. Reproduced from McCallum and Al-Bayati with permission from Practical Gastro.[2,3] The true prevalence of MALS is uncertain as standardized diagnostic criteria have not been established, and patients can vary in presentation. Typically, females are affected (4:1), and the median age is between 30 and 50 years. Patients present with chronic abdominal pain, which may be worsened with exercise and is generally accompanied by nausea, vomiting, and gastroparesis, resulting in food aversion and weight loss. Al-Bayati et al reported that abdominal bruits could be appreciated on physical examination with abdominal auscultation in approximately 35% of patients. Here, we present a case of intermittent epigastric/left upper quadrant pain not helped with omeprazole and requiring some narcotic use before eventually being diagnosed with MALS.

Case Presentation

A 48-year-old female with a past medical history significant for diabetes mellitus, hypertension, hyperlipidemia, and arthritis presented with an 8-month history of intermittent left upper quadrant pain. The pain was described as sharp, nonradiating, with fluctuating intensity (reported to be 10/10 at worst), not associated with meals, and aggravated by positional changes (laying on her right side and direct palpation). She reported having a 3-year history of intermittent postprandial heartburn with particular foods, which was improved, but not completely relieved, by omeprazole 20 mg twice a day. She also endorsed periodic consumption of narcotic medication to alleviate her pain. She denied fever, chills, weight loss, chest pain, shortness of breath, nausea, vomiting, dysphagia, odynophagia, hematemesis, hematochezia, and melena. Physical examination was pertinent for a soft, nondistended abdomen tender to palpation in the left upper quadrant. An abdominal computed tomographic (CT) scan was performed, which was interpreted as having no abnormalities. An esophageal motility study indicated a mildly hypertensive lower esophageal sphincter with the smooth muscle portion of the esophageal body, meeting the criteria for diffuse esophageal spasm. Upper endoscopy was significant for a 1 cm hiatal hernia and an erythematous duodenopathy. Colonoscopy was significant for nonbleeding internal and external hemorrhoids but otherwise normal. A nuclear medicine gastric emptying study was attempted. However, the study was prematurely stopped because the patient did not consume the standardized meal of egg and toast because of premature fullness and satiety. A repeat gastric emptying study was recommended. An abdominal ultrasound with a Doppler suggested a spectral waveform of the celiac artery suspicious for MALS. On inspiration, peak systolic velocity was 297 cm/s, and end-diastolic velocity was 112 cm/s (Figure 2). On expiration, the peak systolic velocity was 607 cm/s, and end-diastolic velocity was 185 cm/s (Figure 2). A mesenteric arteriogram was subsequently performed and confirmed the stenosis of the celiac artery, which was accentuated with end-expiration (Figure 3).
Figure 2.

Preoperative duplex ultrasound with inspiration (Left) and expiration (Right).

Figure 3.

A mesenteric arteriogram confirming stenosis of the celiac artery (Red Arrow).

Preoperative duplex ultrasound with inspiration (Left) and expiration (Right). A mesenteric arteriogram confirming stenosis of the celiac artery (Red Arrow). The patient underwent a robotic laparotomy with a median arcuate ligament release procedure. Preoperatively, the expiration peak velocity was approximately 600 cm/s, and the inspiration peak velocity was approximately 300 cm/s. Intraoperatively, the patient was found to have an expiration peak velocity of 169 cm/s and an inspiration peak velocity of 109 cm/s (Figure 4). Two weeks after the procedure, the patient reported significant improvement in her abdominal pain compared with before her surgery.
Figure 4.

Postoperative duplex ultrasound Doppler with inspiration (Left) and expiration (Right).

Postoperative duplex ultrasound Doppler with inspiration (Left) and expiration (Right).

Discussion

Median arcuate ligament syndrome is a rare entity seen in approximately 0.002% of the population. Females dominate this condition, comprising up to 83.9% of the total MALS patient population. The etiology of this syndrome is interestingly not due to the compression of the celiac artery leading to foregut ischemia but because of compression of the celiac ganglion, along with its associated sympathetic pain fibers by the median arcuate ligament. Before diving into the specifics of this syndrome, it is essential to know when it first fell under the spotlight of medicine. In 1917, Lipshutz was the first to describe what we know as MALS today.[7,8] The clinical presentation typically consists of nausea, vomiting, postprandial pain, and weight loss symptoms, which can also be present across a spectrum of more common etiologies of abdominal pain. Epigastric pain has been the most reported symptom in 100% of patients, weight loss in 48% to 67% of patients, and nausea and diarrhea in approximately 8% to 10% of patients.[8 -10] The MALS can be detected in a percentage of the population who are asymptomatic. The workup focuses on ruling out the more common etiologies of upper abdominal pain such as peptic ulcer disease, gastritis, intestinal ischemia, inflammatory bowel disease, and gallbladder problems. Diagnosis is typically suspected when visualization is seen on a computerized angiogram and Doppler ultrasound. The MALS can confidently be diagnosed with abdominal duplex ultrasound when celiac artery blood flow velocities reach above 200 cm/s during expiration. Our patient reproduced these findings when the duplex ultrasound was performed. The gold standard for MALS diagnosis remains angiography, as it allows direct visual evidence of the celiac artery and celiac ganglion compression accentuated by expiration. Therapeutic intervention of MALS primarily consists of open/laparoscopic surgical release of the median arcuate ligament, which essentially results in celiac ganglionectomy. In a systematic review of 504 cases, patients undergoing laparoscopic treatment were found to have shorter hospital time and a shorter operative time than open surgical release. As the abdominal pain and other symptoms are not related to ischemia, balloon angioplasty is not an option. Another approach is the use of endoscopic ultrasound to guide injection of the celiac plexus with steroids and/or lidocaine. This gives a brief period of relief and could be used as a preoperative trial. If this celiac plexus block is effective, Kim et al describe some emerging therapies with MAL treatment, including robotic-assisted MAL division with neurolysis. Although this method requires further study, current studies suggest it is an effective treatment. Most importantly, patients who underwent surgical decompression experienced immediate postoperative relief in an estimated 80% of patients. Coelho et al, assessed the outcome of patients’ status post-laparoscopic treatment of MAL, all were found to be asymptomatic at a 3-month follow-up. Our patient’s presentation was atypical in that her pain was both epigastric and left upper quadrant pain, which made establishing the diagnosis even more clinically challenging. We present this case of MALS to highlight the importance of maintaining a broad differential diagnosis when assessing abdominal pain. One should particularly include MALS as a possible source when the abdominal pain is not responding to a “standard” approach and is beginning to require narcotic medications to gain control of the pain.

Conclusion

The MALS is an uncommon condition that should be considered after excluding other more common etiologies of abdominal pain, one can consider MALS as a potential culprit. Diagnostic modalities rely on CT angiogram, US Doppler with blood flow, and ultimately angiogram as its gold standard. Surgical release provides the most significant relief, and there is an evolving role for endoscopic ultrasound-guided celiac block.
  11 in total

Review 1.  Median Arcuate Ligament Syndrome-Review of This Rare Disease.

Authors:  Erinn N Kim; Kathleen Lamb; Daniel Relles; Neil Moudgill; Paul J DiMuzio; Joshua A Eisenberg
Journal:  JAMA Surg       Date:  2016-05-01       Impact factor: 14.766

2.  Laparoscopic treatment of median arcuate ligament syndrome: a systematic review.

Authors:  Enrique M San Norberto; Alejandro Romero; Liliana A Fidalgo-Domingos; Irene García-Saiz; James Taylor; Carlos Vaquero
Journal:  Int Angiol       Date:  2019-09-30       Impact factor: 2.789

3.  Median Arcuate Ligament Syndrome in a patient with Crohn's disease.

Authors:  Alessandro Sturiale; Giovanni Alemanno; Francesco Giudici; Rami Addasi; Francesco Bellucci; Francesco Tonelli
Journal:  Int J Surg Case Rep       Date:  2013-01-29

Review 4.  Median arcuate ligament syndrome.

Authors:  Richard Goodall; Benjamin Langridge; Sarah Onida; Mary Ellis; Tristan Lane; Alun Huw Davies
Journal:  J Vasc Surg       Date:  2019-12-25       Impact factor: 4.268

5.  An Atypical Presentation of Median Arcuate Ligament Syndrome.

Authors:  Muhammad Shabbir Rawala; Amna Saleem Ahmed; Syed Rizvi
Journal:  Cureus       Date:  2020-03-16

6.  Treatment of median arcuate ligament syndrome: outcome of laparoscopic approach.

Authors:  Julio Cezar Uili Coelho; Andréa Virmond El Hosni; Christiano MarloPaggi Claus; Yan Sacha Hass Aguilera; Gisele Pitrowsk Abot; Alexandre Teixeira Coutinho de Freitas; Marco Aurélio Raeder da Costa
Journal:  Arq Bras Cir Dig       Date:  2020-05-18

7.  Celiac artery compression syndrome: an experience in a single institution in taiwan.

Authors:  Jen-Wei Chou; Chih-Ming Lin; Chun-Lung Feng; Chun-Fu Ting; Ken-Sheng Cheng; Yung-Fang Chen
Journal:  Gastroenterol Res Pract       Date:  2012-09-04       Impact factor: 2.260

8.  Laparoscopic management of celiac artery compression syndrome: A case report.

Authors:  Sharad Sharma; Vimal Someshwar; Farah Ingale
Journal:  Int J Surg Case Rep       Date:  2020-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.